Wash U Researchers Embark on Targeted Sequencing Project of 450 Childhood Leukemia Samples

Using a pooled, targeted sequencing approach, the team is using the HiSeq to sequence both germline and tumor DNA from children enrolled in high-risk ALL trials, with the goal of finding rare variants that increase a child's risk for developing the disease, act as driver mutations, and affect tumorigenesis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.